enow.com Web Search

  1. Ads

    related to: new treatments for anemia

Search results

  1. Results from the WOW.Com Content Network
  2. Here Are the New Drugs and Treatments We Could See in 2024 - AOL

    www.aol.com/lifestyle/drugs-treatments-could-see...

    2023 was a strong year for innovative new drugs, with new medications for Alzheimer’s disease, ... After approving the first CRISPR treatment, Casgevy, for sickle cell anemia, the FDA is ...

  3. Erythropoiesis-stimulating agent - Wikipedia

    en.wikipedia.org/wiki/Erythropoiesis-stimulating...

    The 2020 Cochrane Anaesthesia Review Group review of erythropoietin (EPO) plus iron versus control treatment including placebo or iron for preoperative anaemic adults undergoing non‐cardiac surgery [11] demonstrated that patients were much less likely to require red cell transfusion and in those transfused, the volumes were unchanged (mean ...

  4. Vadadustat - Wikipedia

    en.wikipedia.org/wiki/Vadadustat

    Vadadustat, sold under the brand name Vafseo, is a medication used for the treatment of symptomatic anemia associated with chronic kidney disease. [2] [3] Vadadustat is a hypoxia-inducible factor prolyl hydroxylase inhibitor. [2]

  5. Daprodustat - Wikipedia

    en.wikipedia.org/wiki/Daprodustat

    Daprodustat, sold under the brand name Duvroq among others, is a medication that is used for the treatment of anemia due to chronic kidney disease. [2] It is a hypoxia-inducible factor prolyl hydroxylase inhibitor. [2] It is taken by mouth. [2] [3] [4]

  6. Sickle cell disease - Wikipedia

    en.wikipedia.org/wiki/Sickle_cell_disease

    The most common type is known as sickle cell anemia. [2] ... In 2021, the NHS initiated its first new treatment in 20 years for Sickle Cell.

  7. Desidustat - Wikipedia

    en.wikipedia.org/wiki/Desidustat

    Desidustat is developed for the treatment of anemia as an oral tablet, where currently injections of erythropoietin and its analogues are drugs of choice. Desidustat is a HIF prolyl-hydroxylase inhibitor. In preclinical studies, effects of desidustat was assessed in normal and nephrectomized rats, and in chemotherapy-induced anemia.

  1. Ads

    related to: new treatments for anemia